medigraphic.com

2015, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S1)

Cutaneous manifestations of leukemia

Pulido N, Medina G, Palomino N, Peralta F

Language: Spanish
References: 18
Page: 30-35
PDF size: 103.76 Kb.


ABSTRACT

Introduction: To describe the type and frequency of cutaneous manifestations of leukemia
Methods: Observational, descriptive study. We included patients over 16 years of age, with confirmed diagnosis of leukemia from the Hematology and Dermatology Departments of the outpatient clinic and from in-patients. Patients with bone marrow transplantation were excluded. A complete history and physical examination of the skin and appendages was performed, with biopsy and cultures if required. The cutaneous manifestations were classified as infection or drug-related, leukemic infiltration, associated dermatosis to leukemia and non-specific lesions. Descriptive statistics was employed.
Results: We included 142 patients (62 females, 80 males) with the following diagnoses: acute myeloid leukemia (n = 36), acute lymphoblastic leukemia (n= 52), chronic myeloid leukemia (n = 21), chronic lymphocitic leukemia (n = 30) and hairy cells leukemia (n = 3). 42 % of patients (n = 60) presented some dermatoses. There were 36 non-specific dermatoses, 21 drug-related, 20 infectious, 3 infi ltrative and none associated.
Conclusions: Cutaneous manifestations directly related to leukemia are frequent, being the non-specific ones, the most commonly observed. However, a thorough dermatologic examination is important in these patients as part of an overall evaluation.


REFERENCES

  1. 1 Linker C. Blood. En: Tierney L, McPhee S, Papadakis M (editors). Current Medical Diagnosis and Treatment. 44th. Ed. Estados Unidos: Mc Graw Hill; 2006, p. 463-517.

  2. Epstein P, Alguire P. Acute leukemias. In: MKSAP (Medical Knowledge Self-Assessment Program). Hematology and Oncology. Estados Unidos: Baylor University Medical Center; 2006, p. 13-18.

  3. Pearson IC, Sirohi B, Powles R, Treleaven J, Mortimer P. The impact on resources of prevalence and nature of skin problems in a modern intensive haematooncology practice. Hematology 2004;9:415-423

  4. Frías-Ancona G, Hierro-Orozco S. Manifestaciones cutáneas en pacientes con alteraciones hematológicas. Dermatología Rev Mex 2007;51:142-48

  5. Sánchez-Hernández C, Crespo-Solís E, Rosas- López A, Archer-Dubon C, Orozco-Topete R. Dermatoses in patients with acute myeloid and lymphoid leukemia. Cohort follow-up in a tertiary care hospital. Rev Invest Clin. 2011;63:353-60.

  6. Heidary N, Naik H, Burgin S. Chemotherapeutic agents and the skin: and update. J Am Acad Dermatol 2008;58:545-70

  7. Tsao AS, Kantarjian H, Cortes J, O’Brien S, Talpaz M. Imatinib mesylate causes hypopigmentation in the skin. Cancer 2003;98:2483–2487.

  8. Breccia M, Latagliata R, Carmosino I, Mandelli F, Alimena G. Reactivation of porphyria cutanea tarda as a possible side effect of imatinib at high dosage in chronic myeloid leukemia. Leukemia 2004; 18: 182.

  9. Pretel-Irazabal M, Tuneu-Valls A, Ormaechea- Pérez N. Adverse Skin Effects of Imatinib, a Tyrosine Kinase inhibitor. Actas Dermosifi liogr. 2013. pii: S0001-7310(13)00108-7.

  10. Oztas P, Erbasi S, Lenk N, Polat M, Han O, Artuz F, Alli N. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia. Acta Derm Venereol. 2006;86: 174-5.

  11. Llamas-Velasco M, Fraga J, Kutzner H, Steegmann JL, García-Diez A, Requena L. Hypopigmented macules secondary to imatinib for the treatment of chronic myeloid leukemia: a histopathologic and immunohistochemical study.J Cutan Pathol. 2014; 41:417-26.

  12. Bonifaz A, Macias B, Paredes-Farrera F, Arias P, Ponce RM, Araiza J. Palatal zygomycosis: experience of 21 cases. Oral Dis. 2008;14:569-74.

  13. Dogan MC, Leblebisatan G, Haytac MC, Antmen B, Surmegozler O. Oral mucormycosis in children with leukemia: report of 2 cases. Quintessence Int. 2007; 38:515-20.

  14. Rodríguez García H, Juárez Navarrete L. Leucemia cutánea. Comunicación de un caso y revisión de la literatura. Dermatologìa Rev Mex 2007;51:20-24

  15. Sharma SK, Gupta S, Seth T, Mishra P, Mahapatra M, Singh MK, Gupta S. Leukemia cutis: an unusual presentation. Indian J Hematol Blood Transfus. 2012;28:175-7.

  16. Rolz-Cruz G, Kim CC. Tumor invasion of the skin. Dermatol Clin 2008; 26: 89-102

  17. Büchner SA. Specifi c and nonspecifi c skin manifestations in leukemia. Praxis (Bern 1994). 2002;91: 1071-7.

  18. Sánchez-Hernández C, Crespo-Solís E, López-Rosas A, Orozco Topete R. Dermatosis en pacientes con leucemia aguda mieloide, linfoide e híbrida. Dermatología Rev Mex 2010;54:188-196.




2020     |     www.medigraphic.com